Home
Home

guidance

Johnson & Johnson expect to incur $100M charge to net income in Q1

Johnson & Johnson expect to incur $100M charge to net income in Q1
The Fly on the Wall

Strong 1Q from Myriad, Guidance Up

Strong 1Q from Myriad, Guidance Up
Yahoo/Zacks.com

Novo hikes forecast on 62% jump in Victoza sales

Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma

Novo raises targets on Victoza, insulin demand

Novo raises targets on Victoza, insulin demand
Yahoo/Reuters

Lilly raises 2012 net profit forecast

Lilly raises 2012 net profit forecast
Reuters

Actelion Raises 2012 Forecast On Reduced First-Half Costs

Actelion Raises 2012 Forecast On Reduced First-Half Costs
Bloomberg

PDL BioPharma expects 2 percent revenue growth on better sales of Herceptin, Lucentis, Tysabri

PDL BioPharma expects 2 percent revenue growth on better sales of Herceptin, Lucentis, Tysabri
Yahoo/AP

Forest Labs cuts outlook on Lexapro discounts

Forest Labs cuts outlook on Lexapro discounts
Yahoo/AP

Teva Issues 2012 Outlook

Teva Issues 2012 Outlook
Yahoo/Zacks

Teva Pharm cuts 2012 sales, profit outlook

Teva Pharm cuts 2012 sales, profit outlook
Reuters